BATF3 and lung carcinoma: Venetoclax injections controlled orthotopic TC1 lung cancers in WT bone marrow-reconstituted mice, but completely failed to do so in mice that were reconstituted with bone marrow from Batf3-deficient donors (Fig. 6E-H).